The Ualcan database analysis further revealed that glioma patients with low ZNRF3 expression had a poor prognosis (P = 0.037), while the expression of the other 6 genes was not associated with the survival of glioma patients (Fig. 4A). This evidence concerns the gene ZNRF3 and central nervous system cancer.